Immuneering Corporation (IMRX)
NASDAQ: IMRX · Real-Time Price · USD
5.50
+0.27 (5.16%)
Apr 8, 2026, 12:51 PM EDT - Market open
Immuneering Market Cap
Immuneering has a market cap or net worth of $355.59 million as of April 8, 2026. Its market cap has increased by 450.48% in one year.
Market Cap
355.59M
Enterprise Value
141.11M
1-Year Change
450.48%
Ranking
Category
Stock Price
$5.50
Market Cap Chart
Since the IPO on July 30, 2021, Immuneering's market cap has decreased from $365.84M to $355.59M, a decrease of -2.80%. That is a compound annual growth rate of -0.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2026 | 338.13M | -20.41% |
| Dec 31, 2025 | 424.87M | 521.96% |
| Dec 31, 2024 | 68.31M | -68.25% |
| Dec 29, 2023 | 215.13M | 67.99% |
| Dec 30, 2022 | 128.06M | -69.91% |
| Dec 31, 2021 | 425.60M | 16.33% |
| Jul 30, 2021 | 365.84M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Invivyd | 367.37M |
| PureTech Health | 364.17M |
| Monopar Therapeutics | 358.72M |
| Niagen Bioscience | 358.71M |
| DiaMedica Therapeutics | 356.70M |
| NervGen Pharma | 355.29M |
| Puma Biotechnology | 350.54M |
| Bicycle Therapeutics | 340.87M |